A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study)

George J. Taylor, H. Weston Moses, Deborah Koester, Jerry A. Colliver, Richard E. Katholi, James T. Dove, Robert C. Woodruff, Frank L. Mikell, Lewis C. Becker, Florence H. Sheehan, W. T. Woods, David P. Hamm, Harry A. Wellons, Joel A. Schneider

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'A difference between front-loaded streptokinase and standard-dose recombinant tissue-type plasminogen activator in preserving left ventricular function after acute myocardial infarction (the Central Illinois Thrombolytic Therapy Study)'. Together they form a unique fingerprint.

Medicine & Life Sciences